Andrew Hall | Chief Executive Officer |
Jeremy Graff | Chief Medical Officer |
Brittany Davison | Senior Vice President, Finance |
Joy Bessenger | Senior Vice President, Investor Relations & Corporate Strategy |
Joseph Pantginis | H.C. Wainwright & Co. |
Nick Abbott | Wells Fargo Securities |
Brandon Folkes | Cantor Fitzgerald |
Paul Stewardson | iA Capital Markets |
Good morning, everyone. I am Joy Besenger, Head of Investor Relations and Corporate strategies for IMV and I'm pleased to welcome you all to our First Quarter 2022 Clinical and Operational Update Conference Call. I'm joined today by Andrew Hall, our CEO, Dr. Jeremy Graff, our CSO and [Indiscernible].
During this call, we will discuss our business outlook and make forward-looking statements.